[PR Newswire] - CAMBRIDGE, Mass., Aug. 28, 2013 /PRNewswire/ -- Genocea Biosciences Inc., a clinical-stage company developing T cell vaccines to prevent and treat infectious diseases, announced today that its abstract ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment